medigraphic.com
ISSN 0185-3252 (Print)
Revista de la Asociación Médica del Centro Médico ABC

2008, Number 1

<< Back Next >>

An Med Asoc Med Hosp ABC 2008; 53 (1)

Ketorolac association in late hematomas after reconstruction with breast expanders

Rodríguez LJJ, Barrantes TM, Pérez VM

Language: Spanish
References: 26
Page: 41-46
PDF size: 110.67 Kb.


ABSTRACT

Hematomas can develop slowly and without symptoms, or rapidly with complex symptomatology. In breast surgery hematomas usually occur around the first 24 hours after surgery and their evacuation is mandatory, under optimal conditions. Some studies show the frequency of these hematomas is less than 2%. In this report we describe a case of slowly developing metachronic hematomas present after four and eight days following breast reconstruction with tissue expanders in a patient that underwent bilateral mastectomy. The patient did not report abnormal bleeding antecedents, hematic pathology, or taking of medications that would have impacted blood clotting or hemostasis. On the fourth day following surgery, the volume of rigth drainage was high with hematic aspect, forcing an exploratory surgery. Contrary to previously reported cases, on the eigth day the patient presented a similar drainage on the left side, that required one more exploratory intervention. Hematologic readings led us to discard bleeding of vascular origin, althought hematologic test were normal. The only thing we can associate as a risk factor is the use of tromethamine ketorolac in those days.


REFERENCES

  1. Labadie EL, Glover D. Physiopathogenesis of subdural hematomas: Histological and biochemical comparisons of subcutaneous hematomas in rats with subdural hematoma in man. J Neurosurgery 1976; 45: 382.

  2. Croning TD, Greenberg RL. Our experiences with the silastic gel breast prostheses. Plast Reconst Surg 1970; 40: 1.

  3. Hsiao HT, Tung KY, Lin CS. Late hematoma after aesthetic breast augmentation with saline-filled, textured silicone prostheses. Aesth Plast Surg 2002; 26 (5): 368-371.

  4. Brickman M, Parsa NN, Parsa FD. Late hematoma after breast implantation. Aesth Plast Surg 2004; 28(2): 80-82.

  5. Wang BH, Chang BW, Sargeant R, Manson PN. Late capsular hematoma after breast reconstruction with polyuretano-covered implants. Plast Reconstr Surg 1998; 102: 450-452.

  6. Spowart K, Greer IA, Mc Laren M, Lloyd J, Bullingham RE, Forbes CD. Haemostatic effects of ketorolac with and without concomitant heparin in normal volunteers. Thromb Haemost 1988; 60 (3): 382-386.

  7. Garcha IS, Bostwick J. Postoperative hematomas associated with toradol. Plast Reconstr Surg 1991; 88 (5): 919-920.

  8. Goyal A, Mansel RE. Hematoma as a late complication after breast reconstruction with implant. Br J Plast Surg 2003; 56 (2): 189-191.

  9. Carney DE et al. Ketorolac reduces postoperative narcotic requirements. J Pediat Surg 2001; 36: 76.

  10. Sharma S, Chang DW, Koutz PAC, Evans GRD, Robb GL, Langstein HN, Kroll SS. Incidence of hematoma associated with ketorolac after TRAM flap breast reconstruction. Plast Reconstr Surg 2001; 107 (2): 352-355.

  11. Singer AJ, Mynster CJ, Mc Mahon BJ. The effect of I.M. Ketorolac tromethamine on bleeding time: A prospective, interventional, controlled study. Am J Emerg Med 2003; 21 (5): 441-443.

  12. Greer IA. Effects of ketorolac tromethamine on hemostasis. Pharmacotherapy 1990; 10 (6): 715.

  13. Conrad KA, Fagan TC, Mackie MJ, Mayshar PV. Effects of ketorolac tromethamine on hemostasis in volunteers. Clin Pharmacol Therap 1988; 43: 642.

  14. RuDusky BM. Severe postoperative hemorrhage attributed to single-dose parenteral ketorolac induced coagulopathy. Angiology 2000; 51 (12): 999-1002.

  15. Forbes JA, Kehm CJ, Grodin CD, Beaver WT. Evaluation of ketorolac, ibuprofen, acetaminophen and acetaminophen-codeine, combination in postoperative oral surgery pain. Pharmacotherapy 1990; 10: 945.

  16. Power I, Noble DW, Douglas E, Spence AA. Comparison of I.M. ketorolac trometadol and morphine sulphate for pain relief, after cholecystectomy. Br J Anaest 1990; 65: 448.

  17. Shufflenberger JV, Doyle J, Roth T, McGuire K, Rothkopf D. The effect of ketorolac on microvascular thrombosis in an experimental rabbit model. Plast Reconstr Surg 1996; 98 (1): 140-145.

  18. Daw JL, Lewis VL, Smith JW. Chronic expanding hematoma within a periprosthetic breast capsula. Plast Reconstr Surg 1996; 97 (7): 1469-1472.

  19. Marquez AF, Brenda E, Saldiva PHN, Andrews JM. Capsular hematoma as a late complication in breast reconstruction with silicone gel prostheses. Plast Reconstr Surg 1992; 89: 543.

  20. Gerogiade NG, Serafin D, Barwick W. Late development of hematoma around a breast implant, necessitating removal. Plast Reconstr Surg 1979; 64: 708.

  21. Mauro S et al. Late recurrent capsular hematoma after augmentation mammaplasty: Case report. Anesth Plast Surg 2005; 29 (1): 10-20.

  22. Vuilleumier H, Halkic N. Ruptured subcapsular hematoma after laparoscopic cholecystectomy attributed to ketorolac-induced coagulopathy. Surg Endosc 2003; 17 (4): 659.

  23. Geisslinger G, Peskar BA, Pallapies D, Sittl R, Levy M, Brune K. The effects on platelet agregattion and prostanoid biosynthesis of two parenteral analgesics: Ketorolac tromethamine and dipyrone. Thromb Haemos 1996; 76 (4) : 592-597.

  24. Power I, Noble DW, Winter A, Greer IA. Effects of ketorolac and dextran-70 alone and in combination on haemostasis. Acta Anaesth Scand 1998; 42 (8): 982–986.

  25. Buckley RC, Davidson SF, Das SK. Effects of ketorolac tromethamine (Toradol) on a functional model of microvascular thrombosis. Br J Plast Surg 1993; 46 (4): 296–299.

  26. Delaporte-Cerceau S, Samama CM, Riou B, Bonnin P, Guillosson JJ, Coriat P. Ketorolac and enoxaparin affect arterial thrombosis and bleeding in the rabbit. Anesthesiology 1998; 88 (5): 1310- 1317.




2020     |     www.medigraphic.com